Home

Andrew C. Orth, Chief Commercial Officer: Krystal Biotech KRYS Sell · Filed 23/06/09

Trade details

Type
Insider sale
Amount
$890,459.64
Shares · price
6,906 sh · $128.94 a share
Held after
433 sh
Trade date
23/06/09
Filed
23/06/09
Days to filing
0 days

Sold 94.1% of holdings

Share of holding sold
94.1%

Krystal Biotech trades, last 26 weeks

What else happened in Krystal Biotech around then

Filed or reported within 30 days of the trade day · 23/05/10~23/07/09

Andrew C. Orth's recent trades

  • Andrew C. Orth

    Sell10b5-1 planKrystal Biotech

    $673.9K

    Filed 23/06/09

  • Andrew C. Orth

    Sell10b5-1 planKrystal Biotech

    $43.2K

    Filed 23/06/09